Longevity News

In his report, Senator Bill Cassidy suggested a slate of changes to the FDA to support broader drug access and to red...

Source: FierceBiotech - All • Published: 18 Feb 2026, 22:00

In his report, Senator Bill Cassidy suggested a slate of changes to the FDA to support broader drug access and to red...

Senator Bill Cassidy released a report proposing multiple FDA reforms aimed at expanding drug access and reducing regulatory burdens on manufacturers.

Read Original Source

Continue exploring

Related longevity signals

Nature - BiotechnologyNovel antimicrobial peptides derived from Brevibacillus laterosporus DSM 25 targeting MurT ligase exhibit broad-spectrum activity against drug-resistant pathogensReports discovery and initial characterization of two antimicrobial peptides from a bacterial proteome that bind MurT ligase and kill drug-resistant bacteria in vitro.Frontiers - HealthClinical benefit without sweat chloride response after ETI therapy in an adult with cystic fibrosis bearing the L467F;F508del complex CFTR allele: a case report and the role of AI-assisted chest CT in longitudinal monitoringA longitudinal case report examines discordant clinical improvement despite absent CFTR chloride biomarker response after triple-modulator therapy, plus AI-assisted chest CT monitoring.Nature - MainA binding-to-release strategy for targeted anticancer drug delivery - NatureCovers a chemistry-driven binding-to-release strategy that enables targeted payload release from cell-surface receptors without cellular internalization, expanding conjugate targets.Longevity TechnologyNRG Therapeutics shows promising lab results for new ALS drug candidateNRG Therapeutics’ preclinical report invites readers to examine lab and mechanistic data for a novel ALS drug candidate and its next-stage plans.